Search results
Results from the WOW.Com Content Network
The National Pharmaceutical Product Index or NAPPI is a comprehensive database of pharmaceutical codes for medical products classification used in South Africa.Each product has a unique NAPPI code which enables electronic data interchange throughout the health care delivery chain.
The National Forensic DNA Database of South Africa (NFDD) is a national DNA database used in law enforcement in South Africa.The Criminal Law (Forensic Procedures) Amendment Act No. 37 of 2013 (the "DNA Act") provides for the expansion and administration of such a database in South Africa, enabling the South African Police Service (SAPS) to match forensic DNA profiles derived from samples ...
As of the Substance Act of 1965, The Medicines Control Council (MCC) and Directorate of Radiation Control (DRC) was formed. As of 2018, the South African Health Products Regulatory Authority (SAHPRA) was created to replace the MCC and DRC [4] [5]
(Reuters) - South African pharmacy chain Clicks Group said on Monday it would sell drug maker Unicorn Pharmaceuticals to comply with a court ruling, clearing the way for the health ministry to ...
National Drug Code (NDC) — administered by Food and Drug Administration. [1] Drug Identification Number (DIN) — administered by Health Canada under the Food and Drugs Act; Hong Kong Drug Registration — administered by the Pharmaceutical Service of the Department of Health (Hong Kong) National Pharmaceutical Product Index - South Africa
The distribution of medications has special drug safety and security considerations. [1] Some drugs require cold chain management in their distribution. [2]The industry uses track and trace technology, though the timings for implementation and the information required vary across different countries, with varying laws and standards.
South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.
The registry traces back to the Health Omnibus Programs Extension Act of 1988 (HOPE or Public Law 100-607) which mandated the development of a database of AIDS Clinical Trials Information System. It would later be expanded under the Food and Drug Administration Modernization Act of 1997 (FDAMA or Public Act 105-115).